Drug Development

Listings
  • Anti-CD79B (Polatuzumab)-Mc-VC-PABC-MMAE ADC

    Anti-CD79B (Polatuzumab)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody conjugated via a Mc-VC-PABC linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within th...

  • Anti-CD79B (Polatuzumab)-VC-MMAE ADC

    Anti-CD79B (Polatuzumab)-VC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody conjugated via a VC linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, ...

  • Anti-CD79b (clone 10D10)-MCC-DM1 ADC

    Anti-CD79b (clone 10D10)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone 10D10) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-CD79b (SN8)-Mc-MMAF ADC

    Anti-CD79b (SN8)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce...

  • Anti-CD79b (SN8)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (SN8)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-CD79b (SN8)-MCC-DM1 ADC

    Anti-CD79b (SN8)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD79b (SN8)-SPP-DM1 ADC

    Anti-CD79b (SN8)-SPP-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (SN8) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone MA79b ) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Anti-CD79b (clone MA79b)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone MA79b ) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD79b (clone ch10D10)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (clone ch10D10)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated end...

  • Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC

    Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 22, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis...